Vaishali Pharma Ltd

Vaishali Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vaishali Pharma Ltd

₹ 4.96 -4.25%
30 Mar 11:09 a.m.
Company website NSE: VAISHALI
About

Incorporated in 1989, Vaishali Pharma Ltd
does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

Key Points

Business Overview:[1]
VPL is certified by ISO 9001:2008 and provides 1500+ products and 250+ Brands including APIs, Formulations, Surgical, Herbals, Veterinary, Nutraceutical, Oncology, and other healthcare products in 35+ locations

Website NSE
  • Market Cap ₹ 64.7 Cr.
  • Current Price ₹ 4.96
  • High / Low ₹ 15.2 / 4.89
  • Stock P/E
  • Book Value ₹ 5.16
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Stock is trading at 1.00 times its book value

Cons

  • Promoter holding is low: 31.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2025 Dec 2025
33.45 24.65
32.06 23.09
Operating Profit 1.39 1.56
OPM % 4.16% 6.33%
0.84 0.89
Interest 0.40 0.51
Depreciation 0.17 0.13
Profit before tax 1.66 1.81
Tax % 28.31% 28.18%
1.19 1.32
EPS in Rs 0.09 0.10
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: 10%
3 Years: -29%
1 Year: -59%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Net Cash Flow
Free Cash Flow
CFO/OP

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2017 Mar 2019 Aug 2020 Feb 2024 Mar 2025
Number of Countries Presence
Number

Log in to view insights

Please log in to see hidden values.

Login
Number of Approved Product Registrations
Number
Number of Customers
Number
Number of Employees
Number
Number of Registered Brands
Number
Number of Brands in Pipeline
Number
Number of Manufacturing Sites (Third Party)
Number
Pending Order Book
INR Crores
Pending Order Book (Formulations/Export)
INR Crores
Total Number of Products
Number

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
26.74% 26.74% 26.62% 26.62% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 31.61%
0.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
72.69% 73.26% 73.38% 73.38% 73.68% 73.68% 73.67% 73.68% 73.68% 73.68% 73.68% 68.39%
No. of Shareholders 9,3769,5739,9839,1819,3909,47918,98327,54628,87428,68227,75227,148

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls